Thermo Fisher Scientific Overview
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. Thermo Fisher Israel operates as a Materials & Structural Analysis Division (MSD), which supplies innovative solutions for microscopy and microanalysis.
Latest News
growth-positive
Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus
The article discusses the recent performance of U.S. stock markets, highlighting gains in major indexes due to cooling inflation data and rising jobless claims. It emphasizes the role of Zacks Investment Research in guiding investors with its methodologies. Notably, Lemonade, Inc. saw a significant stock price increase of 23.4% after being upgraded to a Zacks Rank #2 (Buy) on July 8. Similarly, Interactive Brokers Group experienced a 10.1% rise following a Rank #1 (Strong Buy) upgrade on July 10. The article also mentions the impressive performance of CommScope Holding Company and Wayfair Inc. after their Zacks Recommendation upgrades.
growth-positive
This is the Most Dangerous Week for Investors in 20 Years
The article discusses the potential impact of proposed tariffs by the Trump administration on various industries, including pharmaceuticals, semiconductors, copper, steel, and lumber. The tariffs aim to repatriate manufacturing and reshape the global supply chain. Companies with significant U.S. production, like Eli Lilly, Thermo Fisher Scientific, Intel, and Micron Technology, could benefit from these changes. The tariffs could also boost domestic suppliers like Freeport-McMoRan and Cleveland-Cliffs. The article highlights the potential for a significant shift in the market landscape due to these tariffs, with August 1st being a critical date for implementation.
Growth-Negative
Thermo Fisher Erases $12 Billion Value on China, Biotech Growth Slumps
Thermo Fisher Scientific Inc. has seen a significant drop in its market value, losing more than $12 billion this week. The company, which earns around a tenth of its revenue from China, has been hit by a growth slump in the country and slowing demand from drug makers. This has led to the company cutting its profit outlook for the second time this year. The company now expects adjusted earnings of $21.50 per share for 2023, down from prior expectations of $22.28 to $22.72. The companys stock has lost more than a third of its value from a December 2021 peak.
CustomersLayoffs
Team Members
2
Employees: 201-500
Web & Social Links
| Website | www.thermofisher.com |
Locations
Kiryat Shmona, Israel
Waltham, MA, USA
Photos & Videos
No files yet
Thermo Fisher Scientific Business
Business models
—
Product stage
—
Employees
201-500
Sector
—Target Customer
—Core Technology
—Thermo Fisher Scientific Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
Thermo Fisher Scientific Lifecycle
Thermo Fisher Scientific News
3 articles
growth-positive
Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus
The article discusses the recent performance of U.S. stock markets, highlighting gains in major indexes due to cooling inflation data and rising jobless claims. It emphasizes the role of Zacks Investment Research in guiding investors with its methodologies. Notably, Lemonade, Inc. saw a significant stock price increase of 23.4% after being upgraded to a Zacks Rank #2 (Buy) on July 8. Similarly, Interactive Brokers Group experienced a 10.1% rise following a Rank #1 (Strong Buy) upgrade on July 10. The article also mentions the impressive performance of CommScope Holding Company and Wayfair Inc. after their Zacks Recommendation upgrades.
growth-positive
This is the Most Dangerous Week for Investors in 20 Years
The article discusses the potential impact of proposed tariffs by the Trump administration on various industries, including pharmaceuticals, semiconductors, copper, steel, and lumber. The tariffs aim to repatriate manufacturing and reshape the global supply chain. Companies with significant U.S. production, like Eli Lilly, Thermo Fisher Scientific, Intel, and Micron Technology, could benefit from these changes. The tariffs could also boost domestic suppliers like Freeport-McMoRan and Cleveland-Cliffs. The article highlights the potential for a significant shift in the market landscape due to these tariffs, with August 1st being a critical date for implementation.
Growth-Negative
Thermo Fisher Erases $12 Billion Value on China, Biotech Growth Slumps
Thermo Fisher Scientific Inc. has seen a significant drop in its market value, losing more than $12 billion this week. The company, which earns around a tenth of its revenue from China, has been hit by a growth slump in the country and slowing demand from drug makers. This has led to the company cutting its profit outlook for the second time this year. The company now expects adjusted earnings of $21.50 per share for 2023, down from prior expectations of $22.28 to $22.72. The companys stock has lost more than a third of its value from a December 2021 peak.
CustomersLayoffs
Thermo Fisher Scientific Team
Employee Info
| Employees (range) | 201-500 |
| Exact count | 265 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Thermo Fisher Scientific Internal
Recent Updates
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 17:57:56.000000
Maor Perlov
· maor.perlov@sncentral.org · Automatic · 2024-07-17 13:59:54.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2024-07-17 13:59:54.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2024-12-05 14:48:55.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 18:10:13.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 17:58:52.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2024-12-05 15:13:54.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2024-08-07 04:50:44.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2025-02-06 12:41:12.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 17:57:56.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2024-08-07 05:55:23.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2024-07-17 13:59:54.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 18:10:13.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 17:59:15.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-04 17:57:56.000000
Eran Levin
· eranl@sncentral.org · Automatic · 2024-12-22 06:37:26.000000
Maor Perlov
· maor.perlov@sncentral.org · Automatic · 2024-07-17 13:59:54.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:32.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:31.000000
Jonathan Auerbach
· auerbachhome@gmail.com · Manual · 2019-04-24 20:21:47.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 17:47:33.000000
Maor Perlov
· maorperlov@gmail.com · Manual · 2019-12-24 13:51:22.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 18:32:51.000000
Yanina Wainscheinker
· yanina.wain@gmail.com · Manual · 2019-04-26 18:32:51.000000
Jonathan Auerbach
· auerbachhome@gmail.com · Manual · 2019-04-24 20:24:41.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 69/100 |
| Missing | product stage, sector, founding month, tags, business model, video or image, funding rounds, markets |
| BI Verification | Maor Perlov |
| Crunchbase | thermo-fisher-scientific |
| Phone | +972732560860 |
| Creator | Jonathan Auerbach |
| Creator email | auerbachhome@gmail.com |
| Last updater | Maor Perlov |
| Updater email | maor.perlov@sncentral.org |
| Last update | 2022-11-04T00:00:00.000Z |
| Created | 2019-04-24T00:00:00.000Z |
| Status detail | Public on NYSE on Jan, 2006; |